Brainomix Announces New Phase III INBUILD® Data Highlighting Potential of Quantitative CT to Predict Disease Progression and Assess Treatment Response in Progressive Pulmonary Fibrosis

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Brainomix

More Like This

PR Newswire associated0

Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis

PR Newswire associated0

Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis

PR Newswire associated0

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients

PR Newswire associated0

Brainomix Announces New Studies Further Validating the Impact of Brainomix 360 Stroke Platform

PR Newswire associated0

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates

PR Newswire associated0

Brainomix Stroke AI Software Hailed as ῾Revolutionary,' Helping More Patients Fully Recover

PR Newswire associated0

Brainomix Selected for Prestigious Future Fifty Scale-Up Programme